Swedish HTA council warns on umbilical stem cell use
This article was originally published in Clinica
Executive Summary
There have been too few forward-looking, controlled studies which compare results after the transplantation of different types of stem cells, claims the Swedish Council on Technology Assessment in Health Care (SBU). In an alert issued last week, SBU said that the potential advantages and disadvantages attached to using stem cells gained from umbilical cord blood have not yet been properly explained.